VISHEE(SH:688580) Xin Lang Zheng Quan·2025-09-02 12:19Summary of Key Points Core Viewpoint - WeiSi Medical announced the results of share reduction by certain directors and senior management, indicating compliance with previously disclosed reduction plans [1][3]. Reduction Subject's Pre-Reduction Situation - Before the reduction, Director and CFO Chen Lili held 30,625 shares, accounting for 0.0320% of the total share capital. Vice President and core technician Qiu Kai held 136,500 shares, representing 0.1425% of the total share capital. Both holdings originated from a restricted stock incentive plan and were unrestricted tradable shares [2]. Results of the Reduction Plan Implementation - On May 8, 2025, the company received a notice regarding the share reduction plan from the two shareholders. Chen Lili planned to reduce up to 7,656 shares (0.0080% of total shares) and Qiu Kai planned to reduce up to 34,125 shares (0.0356% of total shares) through centralized bidding within a specified period [3]. - As of the announcement date, Chen Lili had reduced 7,600 shares (0.0079% of total shares) at a price range of 48.40 - 53.46 CNY per share, totaling 400,620.80 CNY, leaving her with 23,025 shares (0.0240%) [3]. - Qiu Kai had reduced 34,000 shares (0.0355% of total shares) at a price range of 45.98 - 46.90 CNY per share, totaling 1,582,713.90 CNY, leaving him with 102,500 shares (0.1070%) [3]. - The actual reduction matched the previously disclosed plan, and the reduction period has concluded without early termination [3].